Matches in Wikidata for { <http://www.wikidata.org/entity/Q90452794> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- Q90452794 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q90452794 description "scientific article published on 17 October 2019" @default.
- Q90452794 description "wetenschappelijk artikel" @default.
- Q90452794 description "наукова стаття, опублікована 17 жовтня 2019" @default.
- Q90452794 name "Suppression of joint destruction with subcutaneous tocilizumab for Japanese patients with rheumatoid arthritis in clinical practice" @default.
- Q90452794 name "Suppression of joint destruction with subcutaneous tocilizumab for Japanese patients with rheumatoid arthritis in clinical practice" @default.
- Q90452794 type Item @default.
- Q90452794 label "Suppression of joint destruction with subcutaneous tocilizumab for Japanese patients with rheumatoid arthritis in clinical practice" @default.
- Q90452794 label "Suppression of joint destruction with subcutaneous tocilizumab for Japanese patients with rheumatoid arthritis in clinical practice" @default.
- Q90452794 prefLabel "Suppression of joint destruction with subcutaneous tocilizumab for Japanese patients with rheumatoid arthritis in clinical practice" @default.
- Q90452794 prefLabel "Suppression of joint destruction with subcutaneous tocilizumab for Japanese patients with rheumatoid arthritis in clinical practice" @default.
- Q90452794 P1433 Q90452794-45316DF2-D37F-4205-961D-A095DF369121 @default.
- Q90452794 P1476 Q90452794-7D78FBAC-7CA9-4631-85B1-81D5E204ADAB @default.
- Q90452794 P2093 Q90452794-114C815D-B1EB-4357-9BE9-D3326BA7E80E @default.
- Q90452794 P2093 Q90452794-12F49AD0-5DAE-422A-A3CF-C273A26FBE27 @default.
- Q90452794 P2093 Q90452794-1E2A4A14-BFC6-47A2-A92D-2AEBD8C3B665 @default.
- Q90452794 P2093 Q90452794-26E14227-DA2C-4215-A844-CF612D62270D @default.
- Q90452794 P2093 Q90452794-2C223C00-2D84-44E6-800F-A0D55E8469FC @default.
- Q90452794 P2093 Q90452794-33711E53-1667-4C25-A9A6-3D8DAA0FF836 @default.
- Q90452794 P2093 Q90452794-46EFE976-F533-4091-86A9-4BA65E8EC7E9 @default.
- Q90452794 P2093 Q90452794-4F7E12CF-8B88-437D-BEEF-9FC047F240D6 @default.
- Q90452794 P2093 Q90452794-5460D83D-0494-4D4E-BEC7-2926B2E8A9F7 @default.
- Q90452794 P2093 Q90452794-5CA33686-1C49-4B8A-9B5D-15CC06D39120 @default.
- Q90452794 P2093 Q90452794-6C945047-3B08-4C0E-BD0D-4FECC8652803 @default.
- Q90452794 P2093 Q90452794-A5CD7C32-D4A1-400A-A122-F2596DC7C0B3 @default.
- Q90452794 P2093 Q90452794-A6B5E74E-4AD1-4CD0-A59F-D8B07E1BF887 @default.
- Q90452794 P2093 Q90452794-A99082DF-BAE7-46A5-A180-94EF19C3B6F2 @default.
- Q90452794 P2093 Q90452794-A9F40698-E0EA-43D7-85E9-6DA8DF6E1A19 @default.
- Q90452794 P2093 Q90452794-B23BBEA4-01FE-478A-B6A0-5BE2910BF87F @default.
- Q90452794 P2093 Q90452794-BEE374EA-4E7D-4CEE-A395-ADA4E981A7FB @default.
- Q90452794 P2093 Q90452794-CA920906-C6E9-4090-996F-4D86F9C507FC @default.
- Q90452794 P2093 Q90452794-CB05051D-F48C-4A32-82DA-6AF1BF719E89 @default.
- Q90452794 P2093 Q90452794-D3C847F7-22F7-4FBB-BCD0-1B7114D06700 @default.
- Q90452794 P2093 Q90452794-D48BF94C-FFC2-47A2-8A33-3428C9F498E0 @default.
- Q90452794 P2093 Q90452794-E50FAFBA-13D4-4B65-8CA1-707B64D7638B @default.
- Q90452794 P2093 Q90452794-EEB37E17-425C-471F-AD35-AA3E6D73A04E @default.
- Q90452794 P304 Q90452794-9E0CED3B-9D99-4E47-BBBF-2CE2B32C016D @default.
- Q90452794 P31 Q90452794-AACFFD53-F8DA-4D3F-BB63-29C6D4975F36 @default.
- Q90452794 P356 Q90452794-A3D6AB21-A86B-48C3-9F2C-8E37F09B5A2A @default.
- Q90452794 P577 Q90452794-AA24640E-A687-4B23-8C46-D25F46E18EEF @default.
- Q90452794 P698 Q90452794-F10C36F6-D60A-40A4-9459-0CDEC7A0C40C @default.
- Q90452794 P921 Q90452794-C4A8E7FA-CA11-4A16-B1D4-071E84B7D5B0 @default.
- Q90452794 P921 Q90452794-C78E36A1-60B0-40A3-A51C-BF6AE2AF9FB2 @default.
- Q90452794 P356 14397595.2019.1676369 @default.
- Q90452794 P698 31580188 @default.
- Q90452794 P1433 Q15752709 @default.
- Q90452794 P1476 "Suppression of joint destruction with subcutaneous tocilizumab for Japanese patients with rheumatoid arthritis in clinical practice" @default.
- Q90452794 P2093 "Akihisa Haraguchi" @default.
- Q90452794 P2093 "Akira Maeyama" @default.
- Q90452794 P2093 "Eiichi Suematsu" @default.
- Q90452794 P2093 "Eisuke Shono" @default.
- Q90452794 P2093 "Hiroshi Harada" @default.
- Q90452794 P2093 "Hiroshi Jojima" @default.
- Q90452794 P2093 "Hiroshi Tsukamoto" @default.
- Q90452794 P2093 "Hisaaki Miyahara" @default.
- Q90452794 P2093 "Ken Wada" @default.
- Q90452794 P2093 "Koji Kuroda" @default.
- Q90452794 P2093 "Masakazu Kondo" @default.
- Q90452794 P2093 "Masayuki Maekawa" @default.
- Q90452794 P2093 "Ryuji Nagamine" @default.
- Q90452794 P2093 "Satoshi Ikemura" @default.
- Q90452794 P2093 "Seiji Yoshizawa" @default.
- Q90452794 P2093 "Shigeru Yoshizawa" @default.
- Q90452794 P2093 "Takaaki Fukuda" @default.
- Q90452794 P2093 "Takashi Ishinishi" @default.
- Q90452794 P2093 "Takashi Shimauchi" @default.
- Q90452794 P2093 "Takeshi Otsuka" @default.
- Q90452794 P2093 "Tomomi Tsuru" @default.
- Q90452794 P2093 "Yasuharu Nakashima" @default.
- Q90452794 P2093 "Yasushi Inoue" @default.
- Q90452794 P304 "1-9" @default.
- Q90452794 P31 Q13442814 @default.
- Q90452794 P356 "10.1080/14397595.2019.1676369" @default.
- Q90452794 P577 "2019-10-17T00:00:00Z" @default.
- Q90452794 P698 "31580188" @default.
- Q90452794 P921 Q187255 @default.
- Q90452794 P921 Q425154 @default.